HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

Market Cap	152.70B
Revenue (ttm)	124.41B
Net Income (ttm)	-4.51B
Shares Out	30.00M
EPS (ttm)	-150.90
PE Ratio	12.38
Forward PE	8.98
Dividend	35.00 (0.69%)
Ex-Dividend Date	Dec 27, 2024

Volume	49,794
Average Volume	81,680
Open	4,850.00
Previous Close	4,850.00
Day's Range	4,820.00 - 4,915.00
52-Week Range	3,825.00 - 6,520.00
Beta	0.75
RSI	75.15
Earnings Date	Aug 4, 2025

About HYUNDAI BIOLAND

Hyundai Bioland Co.,Ltd. along with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices and pharmaceutical raw materials internationally. The company’s cosmetics include whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products; and general/health functional food ingredients. It is also involved in the provision of medical biomedical materials for dental, wound, orthopedic, and biomaterial applications; and the manufacture and supplying of active pha...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 320
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2024, HYUNDAI BIOLAND's revenue was 119.52 billion, an increase of 23.57% compared to the previous year's 96.72 billion. Earnings were 5.70 billion, a decrease of -29.21%.